Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women

ObjectiveAs there is significant heterogeneity in the weight loss response to pharmacotherapy, one of the most important clinical questions in obesity medicine is how to predict an individual’s response to pharmacotherapy. The present study examines patterns of weight loss among overweight and obese...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Megan Rodgers, Alexandra L. Migdal, Tahereh Ghorbani Rodríguez, Zsu-Zsu Chen, Anjali K. Nath, Robert E. Gerszten, Natasha Kasid, Elena Toschi, Juliet Tripaldi, Brent Heineman, Minh Phan, Long Ngo, Eleftheria Maratos-Flier, Jody Dushay
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
overweight
obesity
weight loss
exenatide
hypocaloric diet
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Accès en ligne:https://doaj.org/article/0701fa9ada194f24bff97b3608c895cb
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/0701fa9ada194f24bff97b3608c895cb

Documents similaires